3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Pancreatic Neoplasms
6
Neoplasms
6
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Leukemia, Myeloid, Acute
5
Head and Neck Neoplasms
5
Urinary Bladder Neoplasms
4
Multiple Myeloma
4
Lung Neoplasms
4
Leukemia
4
Colorectal Neoplasms
4
Recurrence
3
Neoplasms, Plasma Cell
3
Hematologic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Rectal Neoplasms
2
Radiodermatitis
2
Neoplasms by Site
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Melanoma
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Communication
2
Carcinoma, Transitional Cell
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Interventions
Darbepoetin alfa
2
piperine
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Whole-Body Irradiation
1
Urination
1
Therapeutics
1
Sucrose
1
Rituximab
1
Phenytoin
1
Peripheral Blood Stem Cell Transplantation
1
Oxycodone
1
Mycophenolic Acid
1
Morphine
1
Methotrexate
1
Methadone
1
Metformin
1
KW-2478
1
Hsp90 inhibitor KU757
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Fentanyl
1
Fatty Acids, Omega-3
1
Epoetin Alfa
1
Early Intervention, Educational
1
Cyclosporine
1
Curcumin
1
Celecoxib
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Monoclonal Gammopathy of Undetermined Significance
×
Standard of Care
×
Clear all
No trials found.